John T. Wei
Impact in
- Urology top 0.02%
- Urinary Bladder and Prostate Research
- Urological Disorders and Treatments
- Pulmonary and Respiratory Medicine top 0.02%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 156
- Prostate Cancer Treatment and Research 53
- Renal cell carcinoma treatment 10
- Urology 67
- Urinary Bladder and Prostate Research 54
- Urological Disorders and Treatments 16
- Co-authors
- Rodney L. Dunn (104 shared papers)Martin G. Sanda (66 shared papers)James E. Montie (78 shared papers)Howard M. Sandler (27 shared papers)Brent K. Hollenbeck (74 shared papers)Mark S. Litwin (18 shared papers)Mark A. Rubin (22 shared papers)David C. Miller (45 shared papers)
- Journals
- The Journal of Urology (132 papers)Urology (49 papers)Cancer (16 papers)Journal of Clinical Oncology (9 papers)British Journal of Urology (8 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
John T. Wei
364 papers receiving 24.1k citations
John T. Wei's Hit Papers
Peers
Comparison fields: 5 of 187
- Urology 3.9k
- Pulmonary and Respiratory Medicine 11.1k
- Cancer Research 2.9k
- Rheumatology 2.4k
- Oncology 2.1k
Countries citing papers authored by John T. Wei
This map shows the geographic impact of John T. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Wei more than expected).
Fields of papers citing papers by John T. Wei
This network shows the impact of papers produced by John T. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Wei. The network helps show where John T. Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside John T. Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 379 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors Hit paper breakdown → | 2008 | 1759 |
| 2 | Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Hit paper breakdown → | 2000 | 1260 |
| 3 | Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia Hit paper breakdown → | 2011 | 864 |
| 4 | Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression Hit paper breakdown → | 2011 | 848 |
| 5 | Integrative molecular concept modeling of prostate cancer progression Hit paper breakdown → | 2006 | 725 |
| 6 | UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA Hit paper breakdown → | 2005 | 638 |
| 7 | Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression Hit paper breakdown → | 2005 | 632 |
| 8 | A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy Hit paper breakdown → | 2016 | 527 |
| 9 | Autoantibody Signatures in Prostate Cancer Hit paper breakdown → | 2005 | 491 |
| 10 | 2012 | 380 | |
| 11 | 2006 | 376 | |
| 12 | A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range Hit paper breakdown → | 2011 | 369 |
| 13 | 2004 | 366 | |
| 14 | 2006 | 365 | |
| 15 | 2002 | 357 | |
| 16 | Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer Hit paper breakdown → | 2006 | 356 |
| 17 | 2010 | 327 | |
| 18 | 2008 | 322 | |
| 19 | 2005 | 319 | |
| 20 | Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment Hit paper breakdown → | 2015 | 293 |
About John T. Wei
John T. Wei is a scholar working on Pulmonary and Respiratory Medicine, Urology, Rheumatology, Surgery and Molecular Biology, having authored 379 papers that have together received 24.8k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (156 papers), Urinary Bladder and Prostate Research (54 papers), Prostate Cancer Treatment and Research (53 papers), Pelvic floor disorders treatments (40 papers), Bladder and Urothelial Cancer Treatments (27 papers), Urological Disorders and Treatments (16 papers), Renal cell carcinoma treatment (10 papers) and Cancer, Lipids, and Metabolism (10 papers). The work is most often cited by research in Urology (3.9k citations), Pulmonary and Respiratory Medicine (11.1k citations), Cancer Research (2.9k citations), Rheumatology (2.4k citations) and Oncology (2.1k citations). John T. Wei has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Rodney L. Dunn, Martin G. Sanda, James E. Montie, Howard M. Sandler, Brent K. Hollenbeck, Mark S. Litwin, Mark A. Rubin, David C. Miller, Arul M. Chinnaiyan and Scott A. Tomlins. Their work appears in journals such as The Journal of Urology, Urology, Cancer, Journal of Clinical Oncology and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.